Learning Objectives:

1. Describe the array and frequency of toxicities associated with immunotherapy.

2. Articulate the unique timing of toxicities that can develop after cancer immunotherapy.

3. Define the management strategies for varied immunotherapy toxicities

Session date: 
04/15/2022 - 8:00am to 9:30am CDT
United States
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Please login or create an account to proceed.
Speaker Name: 
Bruce Brockstein, MD; Nicklas Pfanzelter, MD; Britt Hanson, DO